British scientists are infecting a group of volunteers with a type of malaria that can cause relapses years after contracting ...
GlaxoSmithKline (GSK ... It’s not that the Gates Foundation is snubbing malaria vaccines — as one of Gavi’s biggest donors, Gates is helping to fund the R21 rollout. But rather than put ...
Malaria kills more than a thousand children every day. Measures like antimalarial medications and insecticide-treated bed ...
A malaria vaccine developed by members of the University ... The efficacy is also much higher than the 39% seen with GSK's Mosquirix (RTS,S/AS01), which was, nevertheless, deemed sufficient ...
Singapore President Tharman Shanmugaratnam visited the state-of-the-art Sapigen Biologix vaccine facility in Bhubaneswar, Odisha, which has been established with an investment of Rs 1,500 crore. The ...
A team at GSK has identified what could be an entirely new weapon in the fight to eradicate malaria – but it isn't a new vaccine or antimalarial compound. Working with scientists at Johns ...
TV18’s Shereen Bhan at Davos 2025, Adar Poonawalla, CEO of the Serum Institute of India, emphasised the need for balanced reforms that maintain affordability while enabling companies to generate ...
We recently published a list of 12 Undervalued Defensive Stocks for 2025. In this article, we are going to take a look at ...
Currently, GSK’s Shingrix is the only recombinant vaccine against herpes zoster, also known as shingles, approved for use in China. However, Ab&B’s chances of launching the second recombinant ...
as well as vaccines and consumer healthcare products. Glaxo uses joint ventures to gain additional scale in certain markets like HIV and consumer products. Read More on GB:GSK: Related Stocks Indices ...
Africa reached a pivotal milestone in its decades-long fight against malaria, a disease that has caused 94% of global cases and 95% of related deaths in Africa.1 Although global malaria mortality has ...
The R21/Matrix-M malaria vaccine offers the highest efficacy in the history of malaria vaccine development as reported by Mehreen Datoo and colleagues.1 The potential for saving the lives of African ...